GE HealthCare Technologies (GEHC) Cash from Financing Activities (2022 - 2026)
GE HealthCare Technologies posted quarterly Cash from Financing Activities of $21.0 million for Q1 2026, up 107.34% year-on-year from $10.1 million in Q1 2025, and up 107.17% on a QoQ basis from -$293.0 million in Q4 2025.
GE HealthCare Technologies (GEHC) has 5 years of Cash from Financing Activities data on file, last reported at $21.0 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities rose 107.34% year-over-year to $21.0 million; the trailing twelve-month figure through Mar 2026 stood at $924.0 million (up 230.88% YoY), and the FY2025 full-year result was $617.0 million, up 207.68% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $21.0 million, up from -$293.0 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $1.4 billion in Q2 2025 and bottomed at -$1.3 billion in Q4 2024.
- The 5-year median for Cash from Financing Activities is -$153.0 million (2024), against an average of -$72.6 million.
- The widest annual swing landed in 2023, when Cash from Financing Activities sank 2332.43%; it then jumped 3908.33% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at -$37.0 million in 2022, then tumbled by 2332.43% to -$900.0 million in 2023, then sank by 41.89% to -$1.3 billion in 2024, then soared by 77.06% to -$293.0 million in 2025, then soared by 107.17% to $21.0 million in 2026.
- The last three Cash from Financing Activities figures came in at $21.0 million (Q1 2026), -$293.0 million (Q4 2025), and -$165.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | -369.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.00 Mn |
| Mar 31, 2026 | 21.00 Mn |
| Dec 31, 2025 | -293.00 Mn |
| Dec 31, 2025 | -293.00 Mn |
| Sep 30, 2025 | -165.00 Mn |
| Sep 30, 2025 | -165.00 Mn |
| Jun 30, 2025 | 1.36 Bn |
| Jun 30, 2025 | 1.36 Bn |
| Mar 31, 2025 | -286.00 Mn |
| Mar 31, 2025 | -286.00 Mn |
| Dec 31, 2024 | -1.28 Bn |
| Dec 31, 2024 | -1.28 Bn |
| Sep 30, 2024 | 914.00 Mn |
| Sep 30, 2024 | 914.00 Mn |
| Jun 30, 2024 | -57.00 Mn |
| Jun 30, 2024 | -57.00 Mn |
| Mar 31, 2024 | -153.00 Mn |
| Mar 31, 2024 | -153.00 Mn |
| Dec 31, 2023 | -900.00 Mn |
| Dec 31, 2023 | -900.00 Mn |
| Sep 30, 2023 | -24.00 Mn |
| Sep 30, 2023 | -24.00 Mn |
| Jun 30, 2023 | -227.00 Mn |
| Jun 30, 2023 | -227.00 Mn |
| Mar 31, 2023 | 673.00 Mn |
| Mar 31, 2023 | 673.00 Mn |
| Dec 31, 2022 | -37.00 Mn |
| Dec 31, 2022 | -37.00 Mn |
| Sep 30, 2022 | -505.00 Mn |
| Sep 30, 2022 | -505.00 Mn |
| Jun 30, 2022 | 140.00 Mn |
| Jun 30, 2022 | 140.00 Mn |
| Mar 31, 2022 | -420.00 Mn |
| Mar 31, 2022 | -420.00 Mn |